| systematic review | Q1504425 |
| scholarly article | Q13442814 |
| P50 | author | Suzanna G.m. Frints | Q71589910 |
| P2093 | author name string | C E M de Die-Smulders | |
| L J M Smits | |||
| A D C Paulussen | |||
| L A A P van Winden | |||
| M V E Macville | |||
| A B C Coumans | |||
| E Mersy | |||
| South-East Netherlands NIPT Consortium | |||
| P2860 | cites work | Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci | Q24632266 |
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
| Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms | Q28748932 | ||
| Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. | Q30880746 | ||
| Down syndrome and cell-free fetal DNA in archived maternal serum. | Q31119002 | ||
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker | Q33797671 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma | Q34087801 | ||
| Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | Q34168875 | ||
| Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. | Q34249522 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Diagnostic developments involving cell-free (circulating) nucleic acids | Q36242440 | ||
| Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy | Q36406163 | ||
| Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review | Q36927303 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies | Q37164146 | ||
| Non-invasive prenatal diagnosis by single molecule counting technologies | Q37525261 | ||
| Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age | Q37809306 | ||
| Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies | Q37840679 | ||
| Genomic analysis of fetal nucleic acids in maternal blood | Q38015501 | ||
| Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? | Q38434973 | ||
| Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21. | Q38451572 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. | Q39906674 | ||
| Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease | Q39993125 | ||
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
| Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination | Q45859237 | ||
| Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors | Q46446186 | ||
| Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. | Q46892061 | ||
| Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study. | Q47433348 | ||
| Detection of aneuploidy with digital polymerase chain reaction | Q48567144 | ||
| Advances in prenatal screening: the ethical dimension. | Q48609420 | ||
| Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment. | Q48612533 | ||
| MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21. | Q51340074 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. | Q53063252 | ||
| C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma. | Q54565644 | ||
| Recovery and amplification of placental RNA from dried maternal blood spots: utility for non-invasive prenatal diagnosis. | Q54579005 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasmaSERPINB2mRNA: a feasibility study | Q58029246 | ||
| Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 | Q61847821 | ||
| Quantitative variation analysis of fetal DNA in maternal plasma samples collected before and after amniocentesis | Q61853268 | ||
| Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses | Q73093957 | ||
| Quantitation of fetal DNA in maternal serum in normal and aneuploid prenancies | Q73699759 | ||
| A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study | Q79756571 | ||
| Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21 | Q80512492 | ||
| Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma | Q82261782 | ||
| Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification | Q83388922 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obstetrics and gynaecology | Q80015 |
| reproductive medicine | Q351870 | ||
| systematic review | Q1504425 | ||
| diagnosis | Q16644043 | ||
| P304 | page(s) | 318-329 | |
| P577 | publication date | 2013-02-08 | |
| P1433 | published in | Human Reproduction Update | Q15724523 |
| P1476 | title | Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012 | |
| P478 | volume | 19 |
| Q33914967 | A new model for providing cell-free DNA and risk assessment for chromosome abnormalities in a public hospital setting |
| Q42372436 | A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology |
| Q28072788 | Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis |
| Q64912141 | Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital. |
| Q50461236 | Detection of aneuploidy from single fetal nucleated red blood cells using whole genome sequencing. |
| Q46058669 | Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG). |
| Q35084533 | Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21 |
| Q53125182 | Formative assessment based on an audit and feedback improves nuchal translucency ultrasound image quality. |
| Q38547871 | Genomic futures of prenatal screening: ethical reflection |
| Q24186694 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q41475376 | Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. |
| Q35730355 | Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA--Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis |
| Q36184534 | Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening |
| Q64232954 | Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment |
| Q92839651 | PLAC4 mRNA SNP in non-invasive prenatal testing of Down syndrome |
| Q90259969 | Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing |
| Q56927575 | Recent developments in genetics and medically assisted reproduction: from research to clinical applications |
| Q93118941 | Recent developments in genetics and medically-assisted reproduction: from research to clinical applications†‡ |
| Q61856058 | Risk Perception in Pregnancy |
| Q48095131 | Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous? |
| Q38219313 | Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis |
| Q92384321 | The Contingent Prenatal Screening Test for Down's Syndrome and Neural Tube Defects in West of Iran |
| Q89957907 | The impact of trisomy 21 on epidemiology, management, and outcomes of congenital duodenal obstruction: a population-based study |
| Q38695986 | The outcome of prenatal identification of sex chromosome abnormalities |
| Q37558281 | Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact |
| Q28077443 | Two kinds of common prenatal screening tests for Down's syndrome: a systematic review and meta-analysis |
Search more.